Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dupilumab may help treat alopecia areata, but more research is needed.

Children with Epidermolysis Bullosa need better access to specialized dental care.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Dietary interventions improved hair density and reduced dandruff by balancing scalp microbiota and reducing inflammation.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

Alternative therapies for men's health lack strong scientific support and need more research.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Platelet-rich plasma (PRP) shows promise for treating melasma but needs more research for confirmation.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Platelet-rich plasma (PRP) effectively improves acne scars.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Lower SHBG levels may increase the risk of PCOS.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

It's unclear which molecules best characterize dry skin due to inconsistent findings.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.